Decrease of externalized phosphatidylserine density on red blood cell-derived microparticles in SCA patients treated with hydroxycarbamide

Abstract : Hydroxycarbamide (HC) treatment has been shown to improve the clinical course of patients with sickle cell anaemia (SCA), a haemoglobinopathy resulting from a single base substitution in the bêta-globin gene (HBB). SCA is characterized by chronic haemolytic anaemia and recurrent vascular occlusions leading to multisystemic complications. Several beneficial biological effects of HC have been documented (Halsey et al, 2003) but its impact on the concentration of circulating microparticles (MPs), a subtype of extracellular vesicles released from cytoplasmic membrane of activated or apoptotic cells and detected at high levels in sickle plasma, remains controversial (Hebbel et al, 2016). The aim of the present study was to compare the MP pattern in a group of SCA patients treated by HC and followed for 2 years.
Type de document :
Article dans une revue
British Journal of Haematology, Wiley, A Paraître, 〈10.1111/bjh.14810〉
Liste complète des métadonnées

https://hal.univ-antilles.fr/hal-01668320
Contributeur : Marc Romana <>
Soumis le : mercredi 20 décembre 2017 - 00:17:15
Dernière modification le : jeudi 4 janvier 2018 - 12:18:25

Identifiants

Collections

Citation

Yohann Garnier, Séverine Ferdinand, Philippe Connes, Marie Garnier, Maryse Etienne-Julan, et al.. Decrease of externalized phosphatidylserine density on red blood cell-derived microparticles in SCA patients treated with hydroxycarbamide. British Journal of Haematology, Wiley, A Paraître, 〈10.1111/bjh.14810〉. 〈hal-01668320〉

Partager

Métriques

Consultations de la notice

22

Téléchargements de fichiers

4